1-(4-Trifluoromethyl-phenyl)-cyclobutanol, 98%, 250mg

2-Amino-6-(trifluoromethyl)benzothiazole, 98.0%, 10g

6-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 95.0%, 10g

4-Amino-1-methyl-3-(2-methylpropyl)-1H-pyrazole-5-carboxamide, 95%, 1g

3-Ethyl-2-hydroxycyclopent-2-enone, 95.0%, 5g

2-(4,7,10-TRIS(2-TERT-BUTOXY-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECAN-1-YL)ACETIC ACID, 95%, 100g

2,3,4,5-Tetrahydro-5-oxo-3-thioxo-1,2,4-triazine-6-propanoic acid, 97%, 100mg

1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1H-indazole-4-carboxamide, 98%, 25mg

(3-Fluoro-4-methylphenyl)hydrazine hydrochloride, 95.0%, 250mg

Trial kit Spectra/Por® Biotech CE, 1000000 dalton(s), 1 Piece(s)

3-Methylcrotonic Acid>98.0%(GC)(T)100g

1-Isopropyl-1H-pyrazole-4-carbonitrile, 98%, 1g

1-Methyl-2-oxo-1,2-dihydroquinoline-6-carboxylic acid, 98.0%, 250mg